Donald A. Bergstrom - Jun 28, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Executive Vice President, Head of Research and Development
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Jun 28, 2021
Transactions value $
-$34,951
Form type
4
Date filed
6/30/2021, 06:25 PM
Previous filing
Jun 17, 2021
Next filing
Sep 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$35K -976 -1.26% $35.81 76.3K Jun 28, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 32,812 shares underlying RSUs.

Remarks:

Executive Vice President, Head of Research and Development